Sineos Pharma Partners is Practice Management (Healthcare) in Japan that focus on management business business. Founded in 2007. They cover business area such as provider, clinical development support service, drug development pharmacovigilance information management service, Tokyo, Japan, quality management, data management, audit work, training, drug safety information management business.
Practice Management (Healthcare)
2007
( 17 years old in 2024 )
Management Business
-
141-0031 8-9-5 Nishigotanda, Shinagawa-ku
Tokyo
Japan
Private
providerclinical development support servicedrug development pharmacovigilance information management serviceTokyoJapanquality managementdata managementaudit worktrainingdrug safety information management business
* We use standard office opening hours in near Sineos Pharma Partners's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sineos Pharma Partners is Practice Management (Healthcare) business from Japan that founded in 2007 (17 years old in 2024), Sineos Pharma Partners business is focusing on Management Business.
Sineos Pharma Partners headquarter office and corporate office address is located in 141-0031 8-9-5 Nishigotanda, Shinagawa-ku Tokyo Japan.
Sineos Pharma Partners was founded in Japan.
In 2024, Sineos Pharma Partners is currently focus on management business sector.
Above is snippet of Google Trends for "management business" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sineos Pharma Partners, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
